Molly Hoult

Bio

Molly Hoult has over 20 years of biotechnology, life science and healthcare experience and is a Director in Fletcher Spaght’s Healthcare Consulting Practice. Prior to rejoining the firm in 2009, Molly spent over a decade in marketing and business development roles for various biotechnology and medical device firms including: ZymoGenetics, Blue Heron Biotechnology and NeoPath (which subsequently merged to form TriPath and then was acquired by BD Diagnostics). Prior to earning her MBA, Molly spent five years at Fletcher Spaght and three years as a lab technician in microbial genetics labs. Molly holds an MBA from the Stanford Graduate School of Business and a BA in Biology and Environmental Studies from Dartmouth College.